NSE filing, NSE: IIFL. Summary written from the filing by ALFA Finder's alert engine.
IIFL Finance Ltd: key numbers
- Share price
- ₹533.20
- Market cap
- ₹22,758 Cr
- Revenue (annual)
- ₹13,351 Cr
- Net profit (annual)
- ₹1,661 Cr
- P/E (TTM)
- 9.1×Sector 19.7×
- Promoter holding
- 24.76%-0.09% QoQ
- FII holding
- 25.63%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from IIFL Finance Ltd
All →IIFL Finance Debt & Borrowing: ₹130 Cr
IIFL Finance redeemed Rs. 130.00 Crore commercial paper (INE530B14IG9) at maturity on 26 October 2026. The full redemption leaves zero outstanding CP balance.
- Value
- ₹130.0 Cr
IIFL Finance Management Change
IIFL Finance disclosed that T S Ramakrishnan's tenure as LIC's non-executive nominee director on its board ended on October 25, 2026. The filing gives his resignation letter and the Regulation 30 details.
IIFL Finance Earnings Call Transcript: Key Takeaways
IIFL Finance reported record Q2FY27 PAT of INR 805 Cr, up 93% YoY, driven by 38% AUM growth. Strategy pivots to 90% secured lending with a focus on capital-light co-lending models.
- Call
- Guides 25% growth
IIFL Finance Debt & Borrowing: ₹165 Cr
IIFL Finance successfully redeemed Commercial Paper worth ₹165 Crore upon maturity on October 19, 2026. All redemption payments were made to the beneficiaries as confirmed.
- Value
- ₹165.0 Cr
IIFL Finance Employee Stock Options
IIFL Finance's Nomination and Remuneration Committee approved the grant of 7,00,000 stock options to identified employees under its 2008 Employee Stock Option Scheme.
IIFL Finance Results Update
IIFL Finance reported its financial results for the quarter ended September 30, 2026. The Company highlighted consistent growth in its secured-lending business and robust profitability.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.